Biocryst Pharmaceuticals Stock Price on July 14, 2023

BCRX Stock  USD 7.71  0.01  0.13%   
Below is the normalized historical share price chart for BioCryst Pharmaceuticals extending back to March 04, 1994. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioCryst Pharmaceuticals stands at 7.71, as last reported on the 29th of December, with the highest price reaching 7.79 and the lowest price hitting 7.59 during the day.
IPO Date
3rd of March 1994
200 Day MA
6.7941
50 Day MA
7.639
Beta
1.887
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in BioCryst Stock, it is important to understand the factors that can impact its price. At this stage we consider BioCryst Stock to be somewhat reliable. BioCryst Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0232, which signifies that the company had a 0.0232% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BioCryst Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm BioCryst Pharmaceuticals' Risk Adjusted Performance of 0.0283, mean deviation of 2.32, and Downside Deviation of 3.63 to double-check if the risk estimate we provide is consistent with the expected return of 0.0767%.
  
At this time, BioCryst Pharmaceuticals' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 542.8 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (432.8 M). . Price Earnings To Growth Ratio is likely to rise to 0.47 in 2024, whereas Price To Sales Ratio is likely to drop 3.30 in 2024. BioCryst Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0232

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskBCRXHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.3
  actual daily
29
71% of assets are more volatile

Expected Return

 0.08
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average BioCryst Pharmaceuticals is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioCryst Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book
56.5858
Enterprise Value Ebitda
(12.20)
Price Sales
3.8708
Shares Float
192.7 M
Wall Street Target Price
14.8182

Related Headline

INmune Bio Headline on 14th of July 2023

Filed transaction by Inmune Bio Inc director. General open market or private sale of non-derivative or derivative security

BioCryst Pharmaceuticals Valuation on July 14, 2023

It is possible to determine the worth of BioCryst Pharmaceuticals on a given historical date. On July 14, 2023 BioCryst was worth 7.35 at the beginning of the trading date compared to the closed value of 7.13. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioCryst Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find BioCryst Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioCryst Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioCryst Pharmaceuticals' related companies.
 Open High Low Close Volume
  7.65    7.74    7.31    7.35    2,739,371  
07/14/2023
  7.35    7.35    7.01    7.13    1,744,403  
  7.13    7.40    7.11    7.19    2,853,601  
Backtest BioCryst Pharmaceuticals  |  BioCryst Pharmaceuticals History  |  BioCryst Pharmaceuticals Valuation PreviousNext  
Open Value
7.35
7.13
Closing Value
17.25
Upside

BioCryst Pharmaceuticals Trading Date Momentum on July 14, 2023

On July 17 2023 BioCryst Pharmaceuticals was traded for  7.19  at the closing time. The top price for the day was 7.40  and the lowest listed price was  7.11 . The trading volume for the day was 2.9 M. The trading history from July 17, 2023 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 0.84% . The overall trading delta against the current closing price is 4.91% .
JavaScript chart by amCharts 3.21.1507/14/2023Jul 05Jul 07Jul 09Jul 11Jul 13Jul 15Jul 17Jul 19Jul 21Jul 237.07.17.27.37.4

BioCryst Pharmaceuticals Fundamentals Correlations and Trends

By evaluating BioCryst Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioCryst Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioCryst financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About BioCryst Pharmaceuticals Stock history

BioCryst Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioCryst is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioCryst Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioCryst Pharmaceuticals stock prices may prove useful in developing a viable investing in BioCryst Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding192.2 M201.8 M
Net Loss-222.4 M-211.3 M

BioCryst Pharmaceuticals Quarterly Net Working Capital

273.56 Million

BioCryst Pharmaceuticals Stock Technical Analysis

BioCryst Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BioCryst Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BioCryst Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

BioCryst Pharmaceuticals Period Price Range

Low
December 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

BioCryst Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

BioCryst Pharmaceuticals December 29, 2024 Market Strength

Market strength indicators help investors to evaluate how BioCryst Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioCryst Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying BioCryst Pharmaceuticals stock market strength indicators, traders can identify BioCryst Pharmaceuticals entry and exit signals to maximize returns

BioCryst Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BioCryst Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of BioCryst Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioCryst to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for BioCryst Stock Analysis

When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.